Children's Behavioral Medication Costs Soar

Published Online: Monday, November 1, 2004

Medco Health Solutions 2004 Drug Trend Report has revealed eye-opening data about medication spending to treat behavioral disorders in pediatric patients. Specifically, spending on drugs primarily used to treat attention-deficit/hyperactivity disorder skyrocketed by 369% for children under age 5. The number of children taking 1 or more prescription medications to treat behavior-related conditions hit almost 9% for those children taking at least 1 medication overall. Other significant findings of the analysis are as follows:

  • Prescription drug spending for behavioral conditions rose by 77% between 2000 and 2003 as a result of increased costs and the increased use of these medications
  • In 2003, spending on behavioral medications to treat children overtook both the antibiotic and asthma categories, which are traditionally high-use categories in pediatric medicine
  • The number of children taking behavioral medications jumped by >20% between 2000 and 2003, outpaced only by the increase in children on drugs to treat gastrointestinal conditions, which increased by 28%

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues